CONSULTING AGREEMENTConsulting Agreement • April 16th, 2021 • Leisure Acquisition Corp. • Pharmaceutical preparations • California
THIS CONSULTING AGREEMENT (the “Agreement”), is made and entered into as of the 4th day of August, 2020, by and between PETER COLE (“Consultant”), and COVISTAT, INC., a Delaware corporation (“Client”) (Consultant and Client are sometimes collectively referred to as the “parties” and each individually as a “party”).
INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • April 16th, 2021 • Leisure Acquisition Corp. • Pharmaceutical preparations • California
This Investor Rights Agreement (this “Agreement”) is dated as of the date indicated on the signature pages, by and among Ensysce Biosciences, Inc., a Delaware corporation (“Ensysce”), and each person identified on the signature pages hereto (each, including its successors and assigns, an “Investor” and collectively, the “Investors”).
COMMON STOCK PURCHASE WARRANT To Purchase 100,000 Shares of Common Stock of ENSYSCE BIOSCIENCES, INC.Leisure Acquisition Corp. • April 16th, 2021 • Pharmaceutical preparations • California
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) CERTIFIES that, pursuant to the terms of that certain Warrant Issuance Agreement (the “Issuance Agreement”) and for value received, PAUL VEZOLLES (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, to subscribe for and purchase from ENSYSCE BIOSCIENCES, INC., a corporation incorporated in the State of Delaware (the “Company”), up to 100,000 shares (the “Warrant Shares”) of Common Stock, par value $0.000025 per share, of the Company (the “Common Stock”). The purchase price of one share of Common Stock (the “Exercise Price”) under this Warrant shall be $0.20. The Exercise Price and the number of Warrant Shares for which the Warrant is exercisable shall be subject to adjustment as provided herein.
TECHNOLOGY TRANSFER AGREEMENTTechnology Transfer Agreement • April 16th, 2021 • Leisure Acquisition Corp. • Pharmaceutical preparations • California
THIS TECHNOLOGY TRANSFER AGREEMENT (the “Agreement”) is made and entered into as of the 5th day of August, 2020 (the “Effective Date”), by and between COVISTAT, INC., a Delaware corporation (“Covistat”), MUCOKlNETlCA, LTD, a private limited company of England and Wales (“Mucokinetica”), RODERICK HALL (“Hall’’) and PETER COLE (“Cole”) (collectively, Covistat, Mucokinetica, Hall and Cole are sometimes collectively referred to as the “parties” and each individually as a “party”).
